Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Viruses|January 21, 2023
Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus PolymeraseGilda Giancotti, Giulio Nannetti, Gilda Padalino, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer AgentsAntonio Coluccia, Giuseppe La Regina, Valentina Naccarato, et al.
Journal of Medicinal Chemistry|June 20, 2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 AgentsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
European Journal of Medicinal Chemistry|September 5, 2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strainsMarianna Nalli, Jorge I Armijos Rivera, Domiziana Masci, et al.
European Journal of Medicinal Chemistry|December 11, 2022
RS6077 induces mitotic arrest and selectively activates cell death in human cancer cell lines and in a lymphoma tumor in vivoJessica Sebastiani, Michela Puxeddu, Marianna Nalli, et al.
Oncoimmunology|February 16, 2017
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cellsAlessandra Soriani, Cristiana Borrelli, Biancamaria Ricci, et al.
Journal of Medicinal Chemistry|November 17, 2022
Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly InhibitorMichela Puxeddu, Jianchao Wu, Ruoli Bai, et al.
Journal of Medicinal Chemistry|November 25, 2014
Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Pageof 16